Japan Oncology Molecular Diagnostics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Oncology Molecular Diagnostics market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Oncology Molecular Diagnostics market. Detailed analysis of key players, along with key growth strategies adopted by Oncology Molecular Diagnostics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Exiqon

    • Myriad Genetics

    • Kreatech Holding

    • SensiGen

    • Eragen

    • Predictive Biosciences

    • EXACT Sciences

    • Health Discovery

    • Angsana Molecular and Diagnostics

    • Nuvera Biosciences

    • Hologic

    • QIAGEN

    • NorDiag

    • Vermillion

    • OncoMethylome Sciences

    • GeneNews

    • Cepheid

    • Autogenomics

    • Abbott Diagnostics

    • Becton.Dickinson and Company

    • Beckman Coulter

    • Agendia

    • Innogenetics

    • Asuragen

    • Cangen Biotechnologies

    • Orion Genomics

    • Nanosphere

    • Roche Diagnostics

    • Epigenomics

    • Genomix Biotech

    • Genera Biosystems

    • Genomic Health

    • Diagnocure

    • BioMerieux

    • HTG Molecular

    • Source MDx

    • Prediction Sciences

    • Rosetta Genomics

    • BectonDickinson and Company


    By Type:

    • Type 1

    • Type 2

    • Type 3


    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Molecular Diagnostics Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Type 1 from 2014 to 2026

      • 1.3.2 Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Type 2 from 2014 to 2026

      • 1.3.3 Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Application 1 from 2014 to 2026

      • 1.4.2 Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Application 2 from 2014 to 2026

      • 1.4.3 Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Application 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Oncology Molecular Diagnostics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncology Molecular Diagnostics by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3


    4 Segmentation of Oncology Molecular Diagnostics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncology Molecular Diagnostics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncology Molecular Diagnostics in Application 1

      • 4.4.2 Market Size and Growth Rate of Oncology Molecular Diagnostics in Application 2

      • 4.4.3 Market Size and Growth Rate of Oncology Molecular Diagnostics in Application 3


    5 Market Analysis by Regions

    • 5.1 Japan Oncology Molecular Diagnostics Production Analysis by Regions

    • 5.2 Japan Oncology Molecular Diagnostics Consumption Analysis by Regions


    6 Hokkaido Oncology Molecular Diagnostics Landscape Analysis

    • 6.1 Hokkaido Oncology Molecular Diagnostics Landscape Analysis by Major Types

    • 6.2 Hokkaido Oncology Molecular Diagnostics Landscape Analysis by Major End-Users


    7 Tohoku Oncology Molecular Diagnostics Landscape Analysis

    • 7.1 Tohoku Oncology Molecular Diagnostics Landscape Analysis by Major Types

    • 7.2 Tohoku Oncology Molecular Diagnostics Landscape Analysis by Major End-Users


    8 Kanto Oncology Molecular Diagnostics Landscape Analysis

    • 8.1 Kanto Oncology Molecular Diagnostics Landscape Analysis by Major Types

    • 8.2 Kanto Oncology Molecular Diagnostics Landscape Analysis by Major End-Users


    9 Chubu Oncology Molecular Diagnostics Landscape Analysis

    • 9.1 Chubu Oncology Molecular Diagnostics Landscape Analysis by Major Types

    • 9.2 Chubu Oncology Molecular Diagnostics Landscape Analysis by Major End-Users


    10 Kinki Oncology Molecular Diagnostics Landscape Analysis

    • 10.1 Kinki Oncology Molecular Diagnostics Landscape Analysis by Major Types

    • 10.2 Kinki Oncology Molecular Diagnostics Landscape Analysis by Major End-Users


    11 Chugoku Oncology Molecular Diagnostics Landscape Analysis

    • 11.1 Chugoku Oncology Molecular Diagnostics Landscape Analysis by Major Types

    • 11.2 Chugoku Oncology Molecular Diagnostics Landscape Analysis by Major End-Users


    12 Shikoku Oncology Molecular Diagnostics Landscape Analysis

    • 12.1 Shikoku Oncology Molecular Diagnostics Landscape Analysis by Major Types

    • 12.2 Shikoku Oncology Molecular Diagnostics Landscape Analysis by Major End-Users


    13 Kyushu Oncology Molecular Diagnostics Landscape Analysis

    • 13.1 Kyushu Oncology Molecular Diagnostics Landscape Analysis by Major Types

    • 13.2 Kyushu Oncology Molecular Diagnostics Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Exiqon

      • 14.1.1 Exiqon Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Myriad Genetics

      • 14.2.1 Myriad Genetics Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Kreatech Holding

      • 14.3.1 Kreatech Holding Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 SensiGen

      • 14.4.1 SensiGen Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Eragen

      • 14.5.1 Eragen Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Predictive Biosciences

      • 14.6.1 Predictive Biosciences Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 EXACT Sciences

      • 14.7.1 EXACT Sciences Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Health Discovery

      • 14.8.1 Health Discovery Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Angsana Molecular and Diagnostics

      • 14.9.1 Angsana Molecular and Diagnostics Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Nuvera Biosciences

      • 14.10.1 Nuvera Biosciences Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Hologic

      • 14.11.1 Hologic Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 QIAGEN

      • 14.12.1 QIAGEN Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 NorDiag

      • 14.13.1 NorDiag Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 Vermillion

      • 14.14.1 Vermillion Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

    • 14.15 OncoMethylome Sciences

      • 14.15.1 OncoMethylome Sciences Company Profile and Recent Development

      • 14.15.2 Market Performance

      • 14.15.3 Product and Service Introduction

    • 14.16 GeneNews

      • 14.16.1 GeneNews Company Profile and Recent Development

      • 14.16.2 Market Performance

      • 14.16.3 Product and Service Introduction

    • 14.17 Cepheid

      • 14.17.1 Cepheid Company Profile and Recent Development

      • 14.17.2 Market Performance

      • 14.17.3 Product and Service Introduction

    • 14.18 Autogenomics

      • 14.18.1 Autogenomics Company Profile and Recent Development

      • 14.18.2 Market Performance

      • 14.18.3 Product and Service Introduction

    • 14.19 Abbott Diagnostics

      • 14.19.1 Abbott Diagnostics Company Profile and Recent Development

      • 14.19.2 Market Performance

      • 14.19.3 Product and Service Introduction

    • 14.20 Becton.Dickinson and Company

      • 14.20.1 Becton.Dickinson and Company Company Profile and Recent Development

      • 14.20.2 Market Performance

      • 14.20.3 Product and Service Introduction

    • 14.21 Beckman Coulter

      • 14.21.1 Beckman Coulter Company Profile and Recent Development

      • 14.21.2 Market Performance

      • 14.21.3 Product and Service Introduction

    • 14.22 Agendia

      • 14.22.1 Agendia Company Profile and Recent Development

      • 14.22.2 Market Performance

      • 14.22.3 Product and Service Introduction

    • 14.23 Innogenetics

      • 14.23.1 Innogenetics Company Profile and Recent Development

      • 14.23.2 Market Performance

      • 14.23.3 Product and Service Introduction

    • 14.24 Asuragen

      • 14.24.1 Asuragen Company Profile and Recent Development

      • 14.24.2 Market Performance

      • 14.24.3 Product and Service Introduction

    • 14.25 Cangen Biotechnologies

      • 14.25.1 Cangen Biotechnologies Company Profile and Recent Development

      • 14.25.2 Market Performance

      • 14.25.3 Product and Service Introduction

    • 14.26 Orion Genomics

      • 14.26.1 Orion Genomics Company Profile and Recent Development

      • 14.26.2 Market Performance

      • 14.26.3 Product and Service Introduction

    • 14.27 Nanosphere

      • 14.27.1 Nanosphere Company Profile and Recent Development

      • 14.27.2 Market Performance

      • 14.27.3 Product and Service Introduction

    • 14.28 Roche Diagnostics

      • 14.28.1 Roche Diagnostics Company Profile and Recent Development

      • 14.28.2 Market Performance

      • 14.28.3 Product and Service Introduction

    • 14.29 Epigenomics

      • 14.29.1 Epigenomics Company Profile and Recent Development

      • 14.29.2 Market Performance

      • 14.29.3 Product and Service Introduction

    • 14.30 Genomix Biotech

      • 14.30.1 Genomix Biotech Company Profile and Recent Development

      • 14.30.2 Market Performance

      • 14.30.3 Product and Service Introduction

    • 14.31 Genera Biosystems

      • 14.31.1 Genera Biosystems Company Profile and Recent Development

      • 14.31.2 Market Performance

      • 14.31.3 Product and Service Introduction

    • 14.32 Genomic Health

      • 14.32.1 Genomic Health Company Profile and Recent Development

      • 14.32.2 Market Performance

      • 14.32.3 Product and Service Introduction

    • 14.33 Diagnocure

      • 14.33.1 Diagnocure Company Profile and Recent Development

      • 14.33.2 Market Performance

      • 14.33.3 Product and Service Introduction

    • 14.34 BioMerieux

      • 14.34.1 BioMerieux Company Profile and Recent Development

      • 14.34.2 Market Performance

      • 14.34.3 Product and Service Introduction

    • 14.35 HTG Molecular

      • 14.35.1 HTG Molecular Company Profile and Recent Development

      • 14.35.2 Market Performance

      • 14.35.3 Product and Service Introduction

    • 14.36 Source MDx

      • 14.36.1 Source MDx Company Profile and Recent Development

      • 14.36.2 Market Performance

      • 14.36.3 Product and Service Introduction

    • 14.37 Prediction Sciences

      • 14.37.1 Prediction Sciences Company Profile and Recent Development

      • 14.37.2 Market Performance

      • 14.37.3 Product and Service Introduction

    • 14.38 Rosetta Genomics

      • 14.38.1 Rosetta Genomics Company Profile and Recent Development

      • 14.38.2 Market Performance

      • 14.38.3 Product and Service Introduction

    • 14.39 BectonDickinson and Company

      • 14.39.1 BectonDickinson and Company Company Profile and Recent Development

      • 14.39.2 Market Performance

      • 14.39.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 122 Figures and 157 Tables)

     

    • Figure Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Oncology Molecular Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oncology Molecular Diagnostics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oncology Molecular Diagnostics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncology Molecular Diagnostics by Different Types from 2014 to 2026

    • Table Consumption Share of Oncology Molecular Diagnostics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oncology Molecular Diagnostics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oncology Molecular Diagnostics by Different End-Users from 2014 to 2026

    • Figure Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Oncology Molecular Diagnostics Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Table Japan Oncology Molecular Diagnostics Production by Regions

    • Table Japan Oncology Molecular Diagnostics Production Share by Regions

    • Figure Japan Oncology Molecular Diagnostics Production Share by Regions in 2014

    • Figure Japan Oncology Molecular Diagnostics Production Share by Regions in 2018

    • Figure Japan Oncology Molecular Diagnostics Production Share by Regions in 2026

    • Table Japan Oncology Molecular Diagnostics Consumption by Regions

    • Table Japan Oncology Molecular Diagnostics Consumption Share by Regions

    • Figure Japan Oncology Molecular Diagnostics Consumption Share by Regions in 2014

    • Figure Japan Oncology Molecular Diagnostics Consumption Share by Regions in 2018

    • Figure Japan Oncology Molecular Diagnostics Consumption Share by Regions in 2026

    • Table Hokkaido Oncology Molecular Diagnostics Consumption by Types from 2014 to 2026

    • Table Hokkaido Oncology Molecular Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Oncology Molecular Diagnostics Consumption Share by Types in 2014

    • Figure Hokkaido Oncology Molecular Diagnostics Consumption Share by Types in 2018

    • Figure Hokkaido Oncology Molecular Diagnostics Consumption Share by Types in 2026

    • Table Hokkaido Oncology Molecular Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Oncology Molecular Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Oncology Molecular Diagnostics Consumption Share by End-Users in 2014

    • Figure Hokkaido Oncology Molecular Diagnostics Consumption Share by End-Users in 2018

    • Figure Hokkaido Oncology Molecular Diagnostics Consumption Share by End-Users in 2026

    • Table Tohoku Oncology Molecular Diagnostics Consumption by Types from 2014 to 2026

    • Table Tohoku Oncology Molecular Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Oncology Molecular Diagnostics Consumption Share by Types in 2014

    • Figure Tohoku Oncology Molecular Diagnostics Consumption Share by Types in 2018

    • Figure Tohoku Oncology Molecular Diagnostics Consumption Share by Types in 2026

    • Table Tohoku Oncology Molecular Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Tohoku Oncology Molecular Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Oncology Molecular Diagnostics Consumption Share by End-Users in 2014

    • Figure Tohoku Oncology Molecular Diagnostics Consumption Share by End-Users in 2018

    • Figure Tohoku Oncology Molecular Diagnostics Consumption Share by End-Users in 2026

    • Table Kanto Oncology Molecular Diagnostics Consumption by Types from 2014 to 2026

    • Table Kanto Oncology Molecular Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Kanto Oncology Molecular Diagnostics Consumption Share by Types in 2014

    • Figure Kanto Oncology Molecular Diagnostics Consumption Share by Types in 2018

    • Figure Kanto Oncology Molecular Diagnostics Consumption Share by Types in 2026

    • Table Kanto Oncology Molecular Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Kanto Oncology Molecular Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Oncology Molecular Diagnostics Consumption Share by End-Users in 2014

    • Figure Kanto Oncology Molecular Diagnostics Consumption Share by End-Users in 2018

    • Figure Kanto Oncology Molecular Diagnostics Consumption Share by End-Users in 2026

    • Table Chubu Oncology Molecular Diagnostics Consumption by Types from 2014 to 2026

    • Table Chubu Oncology Molecular Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Chubu Oncology Molecular Diagnostics Consumption Share by Types in 2014

    • Figure Chubu Oncology Molecular Diagnostics Consumption Share by Types in 2018

    • Figure Chubu Oncology Molecular Diagnostics Consumption Share by Types in 2026

    • Table Chubu Oncology Molecular Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Chubu Oncology Molecular Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Oncology Molecular Diagnostics Consumption Share by End-Users in 2014

    • Figure Chubu Oncology Molecular Diagnostics Consumption Share by End-Users in 2018

    • Figure Chubu Oncology Molecular Diagnostics Consumption Share by End-Users in 2026

    • Table Kinki Oncology Molecular Diagnostics Consumption by Types from 2014 to 2026

    • Table Kinki Oncology Molecular Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Kinki Oncology Molecular Diagnostics Consumption Share by Types in 2014

    • Figure Kinki Oncology Molecular Diagnostics Consumption Share by Types in 2018

    • Figure Kinki Oncology Molecular Diagnostics Consumption Share by Types in 2026

    • Table Kinki Oncology Molecular Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Kinki Oncology Molecular Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Oncology Molecular Diagnostics Consumption Share by End-Users in 2014

    • Figure Kinki Oncology Molecular Diagnostics Consumption Share by End-Users in 2018

    • Figure Kinki Oncology Molecular Diagnostics Consumption Share by End-Users in 2026

    • Table Chugoku Oncology Molecular Diagnostics Consumption by Types from 2014 to 2026

    • Table Chugoku Oncology Molecular Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Oncology Molecular Diagnostics Consumption Share by Types in 2014

    • Figure Chugoku Oncology Molecular Diagnostics Consumption Share by Types in 2018

    • Figure Chugoku Oncology Molecular Diagnostics Consumption Share by Types in 2026

    • Table Chugoku Oncology Molecular Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Chugoku Oncology Molecular Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Oncology Molecular Diagnostics Consumption Share by End-Users in 2014

    • Figure Chugoku Oncology Molecular Diagnostics Consumption Share by End-Users in 2018

    • Figure Chugoku Oncology Molecular Diagnostics Consumption Share by End-Users in 2026

    • Table Shikoku Oncology Molecular Diagnostics Consumption by Types from 2014 to 2026

    • Table Shikoku Oncology Molecular Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Oncology Molecular Diagnostics Consumption Share by Types in 2014

    • Figure Shikoku Oncology Molecular Diagnostics Consumption Share by Types in 2018

    • Figure Shikoku Oncology Molecular Diagnostics Consumption Share by Types in 2026

    • Table Shikoku Oncology Molecular Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Shikoku Oncology Molecular Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Oncology Molecular Diagnostics Consumption Share by End-Users in 2014

    • Figure Shikoku Oncology Molecular Diagnostics Consumption Share by End-Users in 2018

    • Figure Shikoku Oncology Molecular Diagnostics Consumption Share by End-Users in 2026

    • Table Kyushu Oncology Molecular Diagnostics Consumption by Types from 2014 to 2026

    • Table Kyushu Oncology Molecular Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Oncology Molecular Diagnostics Consumption Share by Types in 2014

    • Figure Kyushu Oncology Molecular Diagnostics Consumption Share by Types in 2018

    • Figure Kyushu Oncology Molecular Diagnostics Consumption Share by Types in 2026

    • Table Kyushu Oncology Molecular Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Kyushu Oncology Molecular Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Oncology Molecular Diagnostics Consumption Share by End-Users in 2014

    • Figure Kyushu Oncology Molecular Diagnostics Consumption Share by End-Users in 2018

    • Figure Kyushu Oncology Molecular Diagnostics Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Exiqon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Exiqon

    • Figure Sales and Growth Rate Analysis of Exiqon

    • Figure Revenue and Market Share Analysis of Exiqon

    • Table Product and Service Introduction of Exiqon

    • Table Company Profile and Development Status of Myriad Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics

    • Figure Sales and Growth Rate Analysis of Myriad Genetics

    • Figure Revenue and Market Share Analysis of Myriad Genetics

    • Table Product and Service Introduction of Myriad Genetics

    • Table Company Profile and Development Status of Kreatech Holding

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kreatech Holding

    • Figure Sales and Growth Rate Analysis of Kreatech Holding

    • Figure Revenue and Market Share Analysis of Kreatech Holding

    • Table Product and Service Introduction of Kreatech Holding

    • Table Company Profile and Development Status of SensiGen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SensiGen

    • Figure Sales and Growth Rate Analysis of SensiGen

    • Figure Revenue and Market Share Analysis of SensiGen

    • Table Product and Service Introduction of SensiGen

    • Table Company Profile and Development Status of Eragen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eragen

    • Figure Sales and Growth Rate Analysis of Eragen

    • Figure Revenue and Market Share Analysis of Eragen

    • Table Product and Service Introduction of Eragen

    • Table Company Profile and Development Status of Predictive Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Predictive Biosciences

    • Figure Sales and Growth Rate Analysis of Predictive Biosciences

    • Figure Revenue and Market Share Analysis of Predictive Biosciences

    • Table Product and Service Introduction of Predictive Biosciences

    • Table Company Profile and Development Status of EXACT Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EXACT Sciences

    • Figure Sales and Growth Rate Analysis of EXACT Sciences

    • Figure Revenue and Market Share Analysis of EXACT Sciences

    • Table Product and Service Introduction of EXACT Sciences

    • Table Company Profile and Development Status of Health Discovery

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Health Discovery

    • Figure Sales and Growth Rate Analysis of Health Discovery

    • Figure Revenue and Market Share Analysis of Health Discovery

    • Table Product and Service Introduction of Health Discovery

    • Table Company Profile and Development Status of Angsana Molecular and Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Angsana Molecular and Diagnostics

    • Figure Sales and Growth Rate Analysis of Angsana Molecular and Diagnostics

    • Figure Revenue and Market Share Analysis of Angsana Molecular and Diagnostics

    • Table Product and Service Introduction of Angsana Molecular and Diagnostics

    • Table Company Profile and Development Status of Nuvera Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nuvera Biosciences

    • Figure Sales and Growth Rate Analysis of Nuvera Biosciences

    • Figure Revenue and Market Share Analysis of Nuvera Biosciences

    • Table Product and Service Introduction of Nuvera Biosciences

    • Table Company Profile and Development Status of Hologic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hologic

    • Figure Sales and Growth Rate Analysis of Hologic

    • Figure Revenue and Market Share Analysis of Hologic

    • Table Product and Service Introduction of Hologic

    • Table Company Profile and Development Status of QIAGEN

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN

    • Figure Sales and Growth Rate Analysis of QIAGEN

    • Figure Revenue and Market Share Analysis of QIAGEN

    • Table Product and Service Introduction of QIAGEN

    • Table Company Profile and Development Status of NorDiag

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NorDiag

    • Figure Sales and Growth Rate Analysis of NorDiag

    • Figure Revenue and Market Share Analysis of NorDiag

    • Table Product and Service Introduction of NorDiag

    • Table Company Profile and Development Status of Vermillion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vermillion

    • Figure Sales and Growth Rate Analysis of Vermillion

    • Figure Revenue and Market Share Analysis of Vermillion

    • Table Product and Service Introduction of Vermillion

    • Table Company Profile and Development Status of OncoMethylome Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OncoMethylome Sciences

    • Figure Sales and Growth Rate Analysis of OncoMethylome Sciences

    • Figure Revenue and Market Share Analysis of OncoMethylome Sciences

    • Table Product and Service Introduction of OncoMethylome Sciences

    • Table Company Profile and Development Status of GeneNews

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GeneNews

    • Figure Sales and Growth Rate Analysis of GeneNews

    • Figure Revenue and Market Share Analysis of GeneNews

    • Table Product and Service Introduction of GeneNews

    • Table Company Profile and Development Status of Cepheid

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cepheid

    • Figure Sales and Growth Rate Analysis of Cepheid

    • Figure Revenue and Market Share Analysis of Cepheid

    • Table Product and Service Introduction of Cepheid

    • Table Company Profile and Development Status of Autogenomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Autogenomics

    • Figure Sales and Growth Rate Analysis of Autogenomics

    • Figure Revenue and Market Share Analysis of Autogenomics

    • Table Product and Service Introduction of Autogenomics

    • Table Company Profile and Development Status of Abbott Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Diagnostics

    • Figure Sales and Growth Rate Analysis of Abbott Diagnostics

    • Figure Revenue and Market Share Analysis of Abbott Diagnostics

    • Table Product and Service Introduction of Abbott Diagnostics

    • Table Company Profile and Development Status of Becton.Dickinson and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Becton.Dickinson and Company

    • Figure Sales and Growth Rate Analysis of Becton.Dickinson and Company

    • Figure Revenue and Market Share Analysis of Becton.Dickinson and Company

    • Table Product and Service Introduction of Becton.Dickinson and Company

    • Table Company Profile and Development Status of Beckman Coulter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beckman Coulter

    • Figure Sales and Growth Rate Analysis of Beckman Coulter

    • Figure Revenue and Market Share Analysis of Beckman Coulter

    • Table Product and Service Introduction of Beckman Coulter

    • Table Company Profile and Development Status of Agendia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agendia

    • Figure Sales and Growth Rate Analysis of Agendia

    • Figure Revenue and Market Share Analysis of Agendia

    • Table Product and Service Introduction of Agendia

    • Table Company Profile and Development Status of Innogenetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innogenetics

    • Figure Sales and Growth Rate Analysis of Innogenetics

    • Figure Revenue and Market Share Analysis of Innogenetics

    • Table Product and Service Introduction of Innogenetics

    • Table Company Profile and Development Status of Asuragen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Asuragen

    • Figure Sales and Growth Rate Analysis of Asuragen

    • Figure Revenue and Market Share Analysis of Asuragen

    • Table Product and Service Introduction of Asuragen

    • Table Company Profile and Development Status of Cangen Biotechnologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cangen Biotechnologies

    • Figure Sales and Growth Rate Analysis of Cangen Biotechnologies

    • Figure Revenue and Market Share Analysis of Cangen Biotechnologies

    • Table Product and Service Introduction of Cangen Biotechnologies

    • Table Company Profile and Development Status of Orion Genomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orion Genomics

    • Figure Sales and Growth Rate Analysis of Orion Genomics

    • Figure Revenue and Market Share Analysis of Orion Genomics

    • Table Product and Service Introduction of Orion Genomics

    • Table Company Profile and Development Status of Nanosphere

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nanosphere

    • Figure Sales and Growth Rate Analysis of Nanosphere

    • Figure Revenue and Market Share Analysis of Nanosphere

    • Table Product and Service Introduction of Nanosphere

    • Table Company Profile and Development Status of Roche Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Diagnostics

    • Figure Sales and Growth Rate Analysis of Roche Diagnostics

    • Figure Revenue and Market Share Analysis of Roche Diagnostics

    • Table Product and Service Introduction of Roche Diagnostics

    • Table Company Profile and Development Status of Epigenomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Epigenomics

    • Figure Sales and Growth Rate Analysis of Epigenomics

    • Figure Revenue and Market Share Analysis of Epigenomics

    • Table Product and Service Introduction of Epigenomics

    • Table Company Profile and Development Status of Genomix Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomix Biotech

    • Figure Sales and Growth Rate Analysis of Genomix Biotech

    • Figure Revenue and Market Share Analysis of Genomix Biotech

    • Table Product and Service Introduction of Genomix Biotech

    • Table Company Profile and Development Status of Genera Biosystems

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genera Biosystems

    • Figure Sales and Growth Rate Analysis of Genera Biosystems

    • Figure Revenue and Market Share Analysis of Genera Biosystems

    • Table Product and Service Introduction of Genera Biosystems

    • Table Company Profile and Development Status of Genomic Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health

    • Figure Sales and Growth Rate Analysis of Genomic Health

    • Figure Revenue and Market Share Analysis of Genomic Health

    • Table Product and Service Introduction of Genomic Health

    • Table Company Profile and Development Status of Diagnocure

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Diagnocure

    • Figure Sales and Growth Rate Analysis of Diagnocure

    • Figure Revenue and Market Share Analysis of Diagnocure

    • Table Product and Service Introduction of Diagnocure

    • Table Company Profile and Development Status of BioMerieux

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMerieux

    • Figure Sales and Growth Rate Analysis of BioMerieux

    • Figure Revenue and Market Share Analysis of BioMerieux

    • Table Product and Service Introduction of BioMerieux

    • Table Company Profile and Development Status of HTG Molecular

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HTG Molecular

    • Figure Sales and Growth Rate Analysis of HTG Molecular

    • Figure Revenue and Market Share Analysis of HTG Molecular

    • Table Product and Service Introduction of HTG Molecular

    • Table Company Profile and Development Status of Source MDx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Source MDx

    • Figure Sales and Growth Rate Analysis of Source MDx

    • Figure Revenue and Market Share Analysis of Source MDx

    • Table Product and Service Introduction of Source MDx

    • Table Company Profile and Development Status of Prediction Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prediction Sciences

    • Figure Sales and Growth Rate Analysis of Prediction Sciences

    • Figure Revenue and Market Share Analysis of Prediction Sciences

    • Table Product and Service Introduction of Prediction Sciences

    • Table Company Profile and Development Status of Rosetta Genomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Rosetta Genomics

    • Figure Sales and Growth Rate Analysis of Rosetta Genomics

    • Figure Revenue and Market Share Analysis of Rosetta Genomics

    • Table Product and Service Introduction of Rosetta Genomics

    • Table Company Profile and Development Status of BectonDickinson and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BectonDickinson and Company

    • Figure Sales and Growth Rate Analysis of BectonDickinson and Company

    • Figure Revenue and Market Share Analysis of BectonDickinson and Company

    • Table Product and Service Introduction of BectonDickinson and Company

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.